Verbatim response from ChatGPT
Short answer: focus first on metabolic health, lipid/atherosclerotic risk, inflammation, kidney/liver function, anemia/iron status, key vitamins, and a few genetic/aging markers. Those categories consistently predict morbidity and mortality and are actionable.
Which specific blood biomarkers matter most (high priority)
- Lipids and atherosclerotic risk
- LDL-C and non‑HDL cholesterol — core measures of cardiovascular risk.
- Apolipoprotein B (ApoB) and/or LDL particle number (LDL‑P) — better at estimating atherogenic particle burden than LDL‑C alone.
- Lipoprotein(a) [Lp(a)] — genetically determined, important independent risk factor.
- Glucose/insulin metabolism
- HbA1c and fasting glucose — long‑term glycemic control and diabetes risk.
- Fasting insulin and HOMA‑IR (calculated) — early insulin resistance before HbA1c rises.
- Inflammation
- High‑sensitivity CRP (hs‑CRP) — low‑grade inflammation predicts cardiovascular events and mortality.
- Kidney and liver function
- Serum creatinine and estimated GFR — kidney function strongly linked to mortality.
- AST, ALT, GGT, albumin — liver health and nutritional/frailty signal (albumin low = worse outcomes).
- Hematology & iron
- Hemoglobin/hematocrit and complete blood count — anemia and abnormal white cell counts predict worse outcomes.
- Ferritin and transferrin saturation — iron deficiency or iron overload both matter.
- Nutrient/status markers
- 25‑hydroxy vitamin D, vitamin B12, folate — deficiencies raise risks for multiple conditions.
- Coagulation/vascular risk
- Fibrinogen and (in some cases) homocysteine — elevated levels associate with vascular risk.
- Hormones (age/sex dependent)
- Total/free testosterone in men, estradiol/FSH/LH in women as clinically indicated — sex hormone balance affects healthspan.
- Emerging/aging markers (optional, interpret cautiously)
- IGF‑1 — complex (U‑shaped relationships); useful in research/clinical context.
- Omega‑3 index — correlates with cardiovascular risk and is modifiable.
- Epigenetic clocks (DNA methylation age) and telomere length — informative for biological aging but still emerging for clinical decisions.
Which of these are most predictive of longevity?
- Metabolic control (HbA1c/insulin), atherogenic lipids (ApoB/LDL burden), kidney function (eGFR), and chronic inflammation (hs‑CRP/albumin) are among the strongest, most reproducible predictors of lifespan and healthy years.
How often to test
- Generally: annually for healthy adults; every 3–6 months if you’re making interventions, have risk factors, or are older; more often if treating with medications (statins, diabetes drugs, etc.). Let your clinician tailor frequency.
Actions are what matter
- These biomarkers are useful because they point to interventions: diet, weight/waist reduction, exercise, smoking cessation, sleep, blood‑pressure control, targeted supplements when indicated, and medications (e.g., statins, metformin) when appropriate. Always discuss changes with a clinician.
Where to get these tests (services/brands)
- Routine clinical labs (insurance-friendly)
- Quest Diagnostics and Labcorp — broad test menus, accepted by most clinicians and insurers, quick results.
- Consumer/interpretation platforms
- InsideTracker and WellnessFX — pull lab data and provide lifestyle‑focused interpretive guidance and actionable plans.
- Everlywell and LetsGetChecked — convenient home collection kits for some basic tests (good for screening; limited panels).
- Specialized/advanced tests
- OmegaQuant — validated omega‑3 index testing.
- Cleveland HeartLab (and some tests via Labcorp/Quest) — advanced cardiovascular and inflammatory biomarkers.
- TruDiagnostic — epigenetic (DNA methylation) aging clocks for biological-age testing.
- Life Length or TeloYears — telomere length testing (interpret cautiously; use for research/monitoring trends rather than clinical decisions).
- For expert interpretation
- Major clinical centers (Mayo Clinic, Cleveland Clinic) or a specialized preventive cardiology/geroscience clinic — useful if you have complex results or high lifetime risk.
Caveats
- Targets vary by age, sex, and individual risk. Some markers (IGF‑1, telomere length, epigenetic age) are still research‑oriented and not definitive guides for therapy.
- Avoid over‑testing and chasing single numbers; trends over time and overall risk profile matter more.
- Always review abnormal results with a qualified clinician before starting supplements or medications.
If you want, tell me your age, sex, major medical history, and current medications and I’ll give a prioritized, personalized list of which tests to order and typical target ranges to discuss with your clinician.